Latent Hazard in Prostate Cancer and Benign Prostatic Hyperplasia Patients Referred to Antiandrogens: Prostate Cancer Aggressiveness and Neuroendocrine Differentiation

    January 2004 in “ Anticancer Research
    Marko Tarle, Iva Petek, Sunčica Novosel, Zaky Ahel, Zvonko Kusić
    New to Finasteride? There is a guide in the encyclopedia. Read the guide →
    Studysummary This study suggested that long-term finasteride treatment for BPH patients may induce neuroendocrine activity in the prostate, potentially increasing the risk of developing aggressive prostate cancer.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →